Doctors have figured out a way to use herpes to fight untreatable advanced cancer
Roughly two-thirds of the global population has been infected with herpes simplex virus type 1 (HSV-1), which typically causes painful and unsightly blisters around the mouth.
University of Southern California researchers have found a way to rebrand this oft-embarrassing sore subject by genetically modifying HSV-1 and administering it to patients with treatment-resistant, advanced skin cancer along with an anti-cancer medication.
4 About 3.8 billion people worldwide have been infected with herpes simplex virus type 1 (HSV-1), which typically causes painful and unsightly blisters around the mouth.
and.one – stock.adobe.com
In a recent clinical trial, this one-two punch shrank tumors by at least 30% in around one-third of the 140 participants. Nearly one in six saw their tumors completely disappear.
'These findings are very encouraging because melanoma is the fifth most common cancer for adults, and about half of all advanced melanoma cases cannot be managed with currently available immunotherapy treatments,' said Dr. Gino Kim In, a medical oncologist with Keck Medicine of USC.
Advanced melanoma means the skin cancer has spread from its initial location to other parts of the body, such as lymph nodes, the liver or the brain.
Immunotherapy to help the immune system attack cancer cells, targeted therapy and radiation therapy are common treatment options.
4 This is a close-up of the herpes virus, which may hold the key in the battle against advanced melanoma.
BSIP/Universal Images Group via Getty Images
'The survival rate of untreatable advanced melanoma is only a few years, so this new therapy offers hope to patients who may have run out of options to fight the cancer,' In said.
In January, the Food and Drug Administration granted priority review to RP1 (the genetically modified HSV-1) with the anti-cancer medication nivolumab (marketed as Opdivo) for advanced melanoma patients whose cancer had not responded to immunotherapy.
Nivolumab blocks a key protein that cancer cells use to evade the immune system, paving the way for the immune system to recognize and attack these cells.
The idea is that nivolumab would enhance the effects of RP1, which targets, infects and replicates in tumor cells to destroy them — while sparing healthy tissue.
In told The Post that RP1 was developed by knocking out specific genes in HSV-1 so that it no longer causes cold sores.
'Additional genetic modifications were made to the virus to stimulate the immune system to better fight the cancer and to help the virus more efficiently interact with and kill tumor cells,' In said.
4 Nivolumab blocks a key protein that cancer cells use to evade the immune system, paving the way for the immune system to recognize and attack these cells.
luchschenF – stock.adobe.com
In the USC trial, researchers injected RP1 into superficial tumors on or near the skin's surface and into tumors deeper in the body, like in the liver or lungs.
We're Tracking Prime Day Live!
Unlock exclusive NYP codes and real-time deals on everyday must-haves. See Your Deals
The combination therapy was administered every two weeks for up to eight cycles.
Afterwards, the patients who started to see results took just nivolumab every four weeks for up to two years.
Researchers were stunned to notice a difference in the size of the treated and untreated tumors. The untouched tumors shrank or disappeared as often as the injected ones.
'This result suggests that RPI is effective in targeting cancer throughout the entire body and not just the injected tumor,' said In, 'which expands the potential effectiveness of the drug because some tumors may be more difficult or impossible to reach.'
4 Dr. Gino Kim In, a medical oncologist with Keck Medicine of USC, is one of the lead investigators on the trial.
Keck Medicine of USC
RP1 was reported to be well-tolerated among the participants.
Results from the trial were published Tuesday in the Journal of Clinical Oncology and recently presented at the American Society of Clinical Oncology annual meeting.
In and his team launched a phase 3 trial to study the effects of this treatment in over 400 cancer patients.
People interested in participating in the trial, sponsored by RP1 manufacturer Replimune, should contact Sandy Tran at sandy.tran@med.usc.edu.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Los Angeles Times
5 hours ago
- Los Angeles Times
Lawmakers press FDA to target knockoff weight-loss drug
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks. On Friday, a group of more than 80 bipartis an lawmakers asked the US Food and Drug Administration to stop counterfeit and copycat versions of GLP-1 drugs like Wegovy and Zepbound from flooding the market — a problem that emerged over the last year. 'We are concerned about recent reports revealing a surge in illegal and counterfeit anti-obesity medications,' they wrote in a letter to FDA Commissioner Marty Makary. 'Undoubtedly, illegal counterfeit medications pose an increased risk to patient safety with sometimes fatal consequences.' The group — spearheaded by Representatives Richard Hudson of North Carolina and Herb Conaway of New Jersey — asked the agency to ramp up enforcement over illegally imported weight-loss drugs. They suggested issuing warning letters and better monitoring non-compliant online retailers and so-called compounding pharmacies that sell the medicines. The lawmakers also said the FDA should work in tandem with US Customs and Border Patrol agents to stop Chinese entities from shipping unsafe weight-loss drugs into the US. They requested an update on the FDA's efforts by July 30, given the 'urgency' of the situation. A spokesperson for the FDA said the agency will work with the US Department of Health and Human Services to provide a 'complete and thorough' response to the issues raised in the lawmakers' letter. 'Any effort to undermine America's supply of safe medicines is an issue that FDA takes seriously,' the spokesperson said. 'And we are deeply committed to strengthening the oversight of imported products at US ports of entry.' In recent years, the popularity of GLP-1 drugs has led to an explosion of copycats and counterfeits made by companies seeking to capitalize on the hype. State-licensed pharmacies were temporarily allowed to make copies of the drugs during a supply shortage, but are no longer permitted to do so after Novo Nordisk A/S and Eli Lilly & Co. boosted production. Still, some pharmacies have refused to wind down their operations while others have pivoted to selling the drugs in lower doses in order to avoid regulatory scrutiny. Counterfeit drugs are made by unregistered entities typically using illegally imported ingredients. As recently as April, there continue to be instances when counterfeit Ozempic pens covertly enter the drug supply chain undetected. Some patients are also purchasing ingredients directly from online sellers in an attempt to make the drugs themselves at home. In both cases, the medications don't go through the same rigorous approval process as brand-name drugs made by Novo and Lilly. Experts worry the lack of oversight is putting patients at risk. The FDA has said it's aware of hospitalizations potentially linked to the copycat drugs, but that adverse events are likely being underreported. 'We support the bi-partisan call for the FDA to crack down on counterfeit and illegally sold weight-loss drugs,' said a spokesperson for Hims & Hers Health Inc., one of the telehealth firms that sells compounded GLP-1s. 'We appreciate lawmakers' recognition that legitimate compounded medications dispensed by state-regulated pharmacies are not counterfeit. Patient safety must always come first.' Novo and Lilly have discouraged consumers from using compounded and counterfeit products, including suing telehealth firms that sell the copycat versions and working with border agents to seize illegal shipments. Under the Biden administration, the companies repeatedly urged the FDA to take action, but the agency mostly limited its actions to issuing consumer warnings — even as its top drug official publicly acknowledged safety concerns. Under the Trump administration, the HHS has also focused more heavily on other issues, such as banning food dyes and examining vaccine schedules. Meanwhile, lawmakers are ramping up their calls for action. State attorneys and other lawmakers have sent letters to the FDA and Federal Trade Commission advocating for greater transparency around the treatments and more scrutiny around marketing practices. Muller writes for Bloomberg.
Axios
7 hours ago
- Axios
New Air and Space Museum galleries open in D.C.
New galleries will open at the Air and Space Museum on Monday. Why it matters: It marks another completed phase of the Smithsonian museum's almost $1 billion renovation, which began in 2018 and will see all 20 galleries refreshed and 1,400 new artifacts by next year. (Just in time for its 50th anniversary, and the celebration of America's 250th birthday.) State of play: The openings include three existing galleries that got glow-ups, plus two brand-new ones: 👽 Futures in Space: Ponder where space exploration could take us in the future at this new gallery, with cool pieces like an R2-D2 replica and a mock-up of the Blue Origin capsule that took Jeff Bezos to space in 2021. 🌎 Allan and Shelley Holt Innovations Gallery: This new installation will feature a rotating lineup of exhibits focused on innovation in the aerospace world. On display now: A look at how air and space advancements are helping to tackle climate change. 🚀 Boeing Milestones of Flight Hall: The newly refreshed entrance is reopened with museum must-sees like the Mercury Friendship 7 capsule and the Bell X-1, plus new displays. 🛩️ Barron Hilton Pioneers of Flight: Learn about the trailblazers leading the way in aviation during the 1920s and '30s at this revamped gallery, complete with Charles Lindbergh's Spirit of St. Louis plane and Amelia Earhart's Lockheed Vega 5B. 🪖 World War I: The Birth of Military Aviation: This refreshed gallery is all about the first World War's aviation history, with displays like a Sopwith F. 1 Camel and a U.S. balloon basket used for spying. Plus: The museum's renovated Imax theater is now open.
Yahoo
15 hours ago
- Yahoo
Extreme heat is miserable and dangerous. It's also making us age faster
The soupy, smothering extreme heat that has scorched parts of the Northern Hemisphere this summer takes a hard toll on our bodies. It can make you feel nauseous, woozy and dehydrated. It can have pernicious health effects on multiple organs. But there's another, less well-known, impact of extreme heat: It makes you age faster. Prolonged exposure to soaring temperatures can cause a deterioration in our cells and tissues and speed up biological aging, according to a new and growing body of research. Chronological age refers to how long a person has lived, but biological — or 'epigenetic' — age measures how well our tissues and cells function. The difference between the two explains why sometimes someone's age does not seem to match their health and vitality. An accelerated biological age is the 'canary in the coal mine' for future risk of earlier onset of diseases such as cancer, dementia and diabetes, and early death, said Jennifer Ailshire, professor of gerontology and sociology at the University of Southern California Leonard Davis School of Gerontology. As climate change forces people to endure increasingly severe and longer lasting heat waves, scientists say there is an urgency to better understand the ways heat is slowly and silently undermining human health at a cellular level. How does heat accelerate aging? Our DNA is set at birth; it is the blueprint for how the body functions and cannot be changed. But the way DNA is expressed — the way this blueprint is carried out — can be affected by external factors that trigger chemical modifications that turn genes on or off like a light switch. External factors affecting these switches include behaviors, such as smoking and lack of exercise, as well as environmental factors, like heat. Heat stresses the body, making it work harder as it tries to cool down, which can damage cells. While a little bit of heat stress can be good for the body, helping increase resilience, prolonged exposure taxes the body over extended periods and can have long-term consequences. Research on animals has pointed to strong associations between heat and accelerated aging but, until recently, there were very few studies that looked at humans. Ailshire is one of the scientists trying to change that. She and another researcher, Eunyoung Choi, published the first population-scale research into this area in February. They analyzed blood samples taken from a group of more than 3,600 people across the United States aged 56 and above. They used tools called 'epigenetic clocks,' which capture the way DNA is modified and provide an estimate of biological age. They then linked this to daily climate data in participants' locations in the years before the blood samples were taken. Their results, published in February, found people who experienced at least 140 extreme heat days a year — when the heat index, a combination of temperature and humidity, was above 90 degrees Fahrenheit — aged up to 14 months faster than those in locations with less than 10 extreme heat days a year. This link between heat and biological aging remained even when taking into account individual factors such as exercise levels and income, although the study did not look at access to air conditioning or time spent outside. The strength of the association was significant, too. The results showed extreme heat had the same impact on aging as smoking or heavy alcohol use. Their findings are supported by other recent research. A 2023 study of more than 2,000 people in Germany found medium- and long-term exposure to heat was linked to accelerated biological aging. The impacts were particularly pronounced in women, who can be more vulnerable to heat as they tend to sweat less, meaning it's harder for them to cool down. People with diabetes or obesity were also more at risk, the study found. The effects can even start before birth. A 2024 study looked at accelerated biological aging in children in Kenya who were exposed to drought as fetuses. During pregnancy, their mothers endured heat, as well as dehydration and emotional distress. These factors can cause stress at a cellular level that needs to be repaired, which means less energy is available for other vital functions, potentially leading to accelerated aging, the study found. Heat stress can also reduce blood flow to the uterus and placenta. 'So we see an impact on growth that includes lower birth weights and an overall harder start to life — all of which can be reflected in faster biological aging,' said Bilinda Straight, a study author and a professor at the School of Environment, Geography, and Sustainability at Western Michigan University. What can people do? Thiese findings do not mean that everyone living in hot places will experience accelerated aging, Ailshire said. Each person has their own risk factors and there are ways to adapt. Access to cooling and avoiding exercise in the hottest parts of the day are important. Better nutrition, more exercise (in the cool parts of the day) and medication can also help, she added. Scientists have found drugs including metformin, prescribed for diabetes, and weight-loss medication Ozempic could slow aging. If people can change or find ways to adapt to their heat exposure levels, it may be possible to slow or reverse the accelerated aging process, Ailshire said. 'Because that's not permanent damage; it's an indicator of the potential for permanent damage. It doesn't necessarily signify that this damage has been done.' The area of study is very new. 'We are just at the start of understanding this process, particularly in humans,' Rongbin Xu, a research fellow at the School of Public Health and Preventive Medicine at Monash University in Australia. But as places warm up, and heat records continue to be smashed, scientists are going to have a lot more data about the myriad ways heat affects our bodies — and who is most vulnerable. 'If we can't do anything about rising temperatures, then at a minimum, we need to be increasing awareness and finding strategies,' Ailshire said. 'There has to be a way that we can get through this.' Solve the daily Crossword
